ARCHIVES

NCI Advisors Approve Plans To Continue Current Research Programs.

This article is from The Cancer Letter archive.

Vol. 34 No. 26 | July 3, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.

June 30, 2000

In Brief: ESMO Names Annual Award Winners

October 10, 2014

Cancer Mmeetings Lister For Next Three Months

February 23, 1996

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011

Funding opportunities listed.

November 19, 2004

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010